重新评估在口袋里的药片propafenone的安全性
Andrew G Kim1, Majid Yavari2, Rand Sabanci1
1Internal Medicine, Michigan State University, East Lansing, USA.
与β阻塞剂或通道阻塞剂相结合的普罗帕芬可以转换心房动,但由于药物相互作用和遗传因素,有心脏性休克的风险. 这一案例突出显示了在监控环境下的严重毒性.
科学领域:
- 心脏病学 心脏病学
- 临床药理学 临床药理学
- 药物基因组学 药物基因组学
背景情况:
- 目前的指导方针允许在特定患者中与β阻塞剂或通道阻塞剂相结合,用于最近出现的心房动 (AF).
- 建议在服用β-阻断剂或通道阻断剂后服用普罗帕芬,以防止心房动与快速心室反应.
更多相关视频
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Assessment of apical pulse
Assessing the apical pulse is a critical nursing procedure, particularly indicated for:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
